Stay updated with breaking news from Timothyp Walbert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) CEO Timothy P. Walbert sold 25,000 shares of the business’s stock in a transaction dated Friday, April 22nd. The stock was sold at an average price of $106.59, for a total value of $2,664,750.00. Following the transaction, the chief executive officer now directly owns 485,549 shares of […]
Wells Fargo & Company reissued their buy rating on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) in a research report report published on Friday, TipRanks reports. The firm currently has a $133.00 price target on the biopharmaceutical company’s stock. Several other analysts also recently commented on HZNP. Piper Sandler lowered their target price […]
Oppenheimer Asset Management Inc. decreased its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 1.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 43,068 shares of the biopharmaceutical company’s stock after selling 676 shares during the period. Oppenheimer Asset Management […]
New York State Teachers Retirement System purchased a new stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,300 shares of the biopharmaceutical company’s stock, valued at approximately […]
StockNews.com assumed coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms have also issued reports on HZNP. Zacks Investment Research raised Horizon Therapeutics Public from a […]